Last reviewed · How we verify
NCT03497728
Detection of Microdeletions in the Azoospermia Factor (AZF) Regions in Infertile Male Patients
trial in Azoospermia or Severe Oligozoospermia in 5,000 participants. Terminated before completion.
1 September 2021
Quick facts
| Lead sponsor | Reproductive & Genetic Hospital of CITIC-Xiangya |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 4 December 2017 |
| Primary completion | 1 September 2021 |
| Estimated completion | 1 December 2021 |
| Sites | 1 location across China |
Conditions studied
- Azoospermia or Severe Oligozoospermia — all drugs for Azoospermia or Severe Oligozoospermia →
Sponsor
Reproductive & Genetic Hospital of CITIC-Xiangya
Who can join
18 and older, male only, with Azoospermia or Severe Oligozoospermia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this prospective study, we used Multiplex ligation-dependent probe amplification and next-generation sequencing technology to detect AZF microdeletion types accurately in selected genetic locus, and made correlation analysis with clinical treatment results.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03497728
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Reproductive & Genetic Hospital of CITIC-Xiangya trials
Trials by the same sponsor.
- NCT05227391 — Live Birth After Letrozole-stimulated Cycles Versus Hormone Replacement Treatment Cycles for the First Frozen Embryo Tra · NA · unknown
- NCT04639505 — Predictive Value of New AMH Test Method for Ovarian Response · completed
- NCT04538560 — Preimplantation Genetic Testing for Aneuploidy of Polar Bodies · NA · unknown
- NCT03910582 — Personalized FET in RIF Patients With Displaced Dating · NA · unknown
- NCT04178135 — Recombinant LH Supplementation Timing Strategies (From Day 1 or Day 6) to a Standard GnRH Agonist Long Protocol in Subse · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03497728 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Reproductive & Genetic Hospital of CITIC-Xiangya
- Last refreshed: 26 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03497728.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing